You searched for Antibody candidate - Page 12 of 69

News and Trends 9 Mar 2016

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

…attract Pharma’s attention (and money). This time, two of 25 leading Big Pharma worldwide, AbbVie and Boehringer Ingelheim, have partnered to develop 2 different immunological candidates. One of the candidates…

March 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 2 Nov 2017

Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II

…antibody’s efficacy and safety. AC Immune’s anti-Tau monoclonal antibody is based on the company’s SupraAntigen technology. They are generated by injecting the SupraAntigen constructs into mice and selecting antibodies that…

November 2, 2017 - 2 minutesmins - By Alex Dale

In Depth 4 Feb 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

…the problems faced with getting small molecules to bind to these targets have been addressed, making sotorasib the first KRAS inhibitor to be approved in 2021. Now, candidates like divarasib…

February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 23 Mar 2023

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of the latter’s lead candidate ONC-392, for the treatment of cancer….

March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…Among them is a vaccine for malaria, which has received significant attention and funding, including $12.2 million from the EU Malaria Fund. Another prominent candidate is MAbCo19, a monoclonal antibody…

August 22, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 5 Mar 2025

Seven biotech companies keeping Taiwan dynamic in 2025

…to enter the U.S. market in over 15 years. OBI Pharma Technology: Antibody-drug conjugate (ADC) platform targeting TROP2 Lead candidate: OBI-992 Recent news: Received FDA orphan drug designation for OBI-992…

March 5, 2025 - 8 minutesmins - By Jules Adam

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…RNA (mRNA) molecules, leading to mRNA degradation or inhibition of protein translation. Several companies are advancing candidates relying on miRNAs in 2024. miRNAs have garnered significant attention due to their…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 14 Nov 2016

Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire

…never had to write one before. Conversely, an attractive CV could hide a candidate’s lack of experience or exaggerations. For instance, did the candidate lead a project or merely participate…

November 14, 2016 - 6 minutesmins - By External Contributor

Expert Advice 14 Dec 2020

How to Hire and Retain Talent in the Biotech Industry

…specific profiles in the market, but as technology evolved candidates also had to evolve and develop new skills.” In addition, the number of qualified candidates for life sciences positions has…

December 14, 2020 - 7 minutesmins - By Clara Rodríguez Fernández

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

…have not always had an easy ride. “Significant investment, in both time and money, is needed to advance a vaccine candidate to market,” Thomas Lingelbach, CEO of French vaccine developer…

May 18, 2020 - 13 minutesmins - By Helen Albert

In Depth 9 Apr 2025

Cystic fibrosis: is the next blockbuster a gene therapy?

…this article, we will explore how gene therapy works, the biotechs progressing their genetic drug candidates, and why it might just be the breakthrough that people with cystic fibrosis have…

April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 14 Mar 2024

7 oncolytic virus companies you should know about

…it has developed an extensive library of isolated and engineered oncolytic vaccinia virus (a poxvirus similar to smallpox) immunotherapeutic product candidates. The oncolytic virus company’s most advanced candidate, Olvi-Vec (olvimulogene…

March 14, 2024 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

Seven companies transforming the biotech industry in Italy

Seven biotech companies keeping Taiwan dynamic in 2025

Seven miRNA-focused companies pioneering new therapies in 2024

Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire

How to Hire and Retain Talent in the Biotech Industry

Will Covid-19 Change the Face of Vaccine Development?

Cystic fibrosis: is the next blockbuster a gene therapy?

7 oncolytic virus companies you should know about

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!